← Leaderboards
Rebecca M Harman
Cornell University
$636,603
Attributed
$636,603
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $411.9K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$636,603 · 2
By mechanism
R21$636,603 · 2
Top collaborators
No co-investigators on record.
Most similar at Cornell University
Same institution · by research overlap
- Anil J Thachil$216,811
- Laura Brunengraber Goodman$2,869,197
- Michael J Stanhope$2,802,223
- Karyn Bischoff$853,078
- Patrick L McDonough$11,101
Others in their field
Other Rising Stars on “Mammary Neoplasms”
- Amy Fowler · University Of Wisconsin-Madison$3,970,631
- Evanthia Theodosiou Roussos Torres · University Of Southern California$2,679,821
- Jennifer M. Rosenbluth · University Of California, San Francisco$2,657,653
- Irida Kastrati · Loyola University Chicago$2,252,222
- Gerson David Hernandez · University Of Arizona$2,098,361
- Shadi Saberi · Isono Health, Inc.$1,999,730
Research focus
Mammary NeoplasmsXenograft ProcedureInnovationMammaryResistanceTumorDna DamageIncidenceIn VitroMammalsMouse ModelRepairedResponseStemCancer TypeCellsApoptosisEquus CaballusApoptoticInsightIn VivoMalignant NeoplasmsMediatingBehavior
Grant awards (4)
The mammary cell secretome as a novel biologic for triple-negative breast cancer$220,193
R21 · FY2025 · CA · contact PI
Environmental mammary carcinogen evaluation in a xenotransplantation mouse model$4,520
R21 · FY2025 · ES · contact PI
Environmental mammary carcinogen evaluation in a xenotransplantation mouse model$228,396
R21 · FY2024 · ES · contact PI
The mammary cell secretome as a novel biologic for triple-negative breast cancer$183,494
R21 · FY2024 · CA · contact PI